Efficacy of Jatyadi Kwatha Gandusha in Management of Pittaja Mukhapaka with special reference to Aphthous Ulcer: A Randomized Controlled Clinical Trial
Keywords:Pittaja Mukhapaka, Jatyadi Kwatha, Ayurvedic polyherbal Drug, Gandusha, Triphala Kwatha
The condition known as Pittaja Mukhapaka is frequently encountered by patients seeking treatment at the outpatient department of the Ears, Nose, and Throat department. This condition is characterized by inflammation, ulceration, and a burning sensation in the oral mucosa, and is often associated with Aphthous ulcers (Pittaja Mukhapaka). Although modern medicine has several treatment options, including anti-inflammatory drugs, topical corticosteroids, and topical tetracyclines, these treatments have limitations. In contrast, Jatyadi Kwath Churna is a traditional polyherbal composition in ayurvedic medicine that has been used to treat oral problems for centuries. This herbal preparation contains Jati Patra, Guduchi, Draksha, Daru Haridra, Yavasa, Haritaki, Vibhitaki, Madhu, and Amlaki, and is indicated for oral problems in the texts Yogaratnakara and Bhaishajya Ratnavali. Material and Methods: This study aims to evaluate the efficacy of Jatyadi Kwatha Gandusha for Mukha Rogas, a study was conducted with 30 subjects randomly allocated to either Group A (receiving Gandusha of Jatyadi Kwatha and Madhu) or Group B (receiving Triphala Kwatha). Result: Both groups experienced complete relief from discomfort, burning sensations, and excessive salivation, on analysis between the groups with a statistically significant p-value results are equally effective in both groups. Conclusion: The study successfully demonstrated the effectiveness of Jatyadi Kwatha Gandusha and Triphala Kwatha in managing Pittaja Mukhapaka.
How to Cite
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.